← Entities
Public Body
Instituto para os Comportamentos Aditivos e as DE.P.E.ndências, I. P.
NIF 517839539
· PT
Risk Flags
A1 · Repeat Direct Award
€191,857
17 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH
€191,857
17 contracts
A2 · Late Publication
€5,574,076
259 contracts
Contract published to BASE more than 10 days after the signing date
LOW
€5,574,076
259 contracts
A5 · Threshold Splitting
€488,851
8 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH
€488,851
8 contracts
A9 · Abnormal Price Reduction
€4,318,466
205 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW
€4,318,466
205 contracts
B5 · Benford's Law Deviation
€8,852,878
316 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM
€8,852,878
316 contracts
Procurement Network
Aggregated links between this entity and connected counterparties
Public view excludes person-level links and tax identifiers.
Loading network…
No connections found for the current filters.
Legend
Focus entity
Public body
Company
Anonymized individual
Signal:
All
A1 · Repeat Direct Award
A2 · Late Publication
A5 · Threshold Splitting
A9 · Abnormal Price Reduction
B5 · Benford's Law Deviation
C1 · Missing Supplier NIF
C3 · Missing Mandatory Fields
Page 1 of 1 · 3 results
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2021/61 - Medicamentos diversos; 2022/10 - Material de penso de efeito terapêutico; 2022/14 - Medicamentos do aparelho digestivo; 2022/19 - Medicamentos antipsicóticos, anestésicos e relaxantes musculares; 2022/173 - Medicamentos diversos; 2023/304 - Medicamentos do grupo 4: sangue; 2023/305 - Medicamentos do aparelho cardiovascular; 2023/436 - Medicamentos para o sistema nervoso central; 2023/437 - Medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações; 2023/490 - Medicamentos usados em afeções cutâneas; 2023/492 - Medicamentos anti-infeciosos; 2023/671 - Medicamentos diversos; 2024/780 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas; 2024/782 - Medicamentos usados em afeções oculares e otorrinolaringológicas; 2024/898 - Medicamentos analgésicos, antipiréticos e antidepressivos; 2024/899 - Medicamentos do aparelho respiratório
PT · 11586831
A2 · Late Publication
A9 · Abnormal Price Reduction
+1
—
Ao abrigo de acor...
€666,610
2025-03-02
€666,610
2025-03-02
Aquisição de Comunicações Fixas ICAD
PT · 11756172
A2 · Late Publication
C1 · Missing Supplier NIF
—
Ao abrigo de acor...
€8,069
2025-02-17
€8,069
2025-02-17
Convite ao abrigo do(s) acordo(s)-quadro 2021/012; 2021/044; 2021/047; 2022/010; 2022/014; 2022/019; 2022/173; 2022/8; 2023/304; 2023/305; 2023/306; 2023/436; 2023/481; 2023/490; 2023/492; 2023/671 e 2024/780, para aquisição de medicamentos e para suprir necessidades na área da saúde.
PT · 10968364
A2 · Late Publication
A9 · Abnormal Price Reduction
+1
—
Ao abrigo de acor...
€12,749
2024-07-16
€12,749
2024-07-16
Overview
Total Contracts
316
Score 14430 · CRITICAL RISK
Digit Distribution
n = 316 contracts
· χ² = 44.5231
1
20.3%
2
21.5%
3
10.1%
4
11.4%
5
12.3%
6
12.7%
7
5.4%
8
2.5%
9
3.8%
Observed
Expected (Benford)